Adjuvant Chemotherapy in Embryonal Carcinoma of the Testis (Q39556170)

13 September 2017

Adjuvant Chemotherapy in Embryonal Carcinoma of the Testis (English)

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

16 November 2022

1 reference

E. Pommatau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A88751

16 November 2022

C. Ardiet

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A88751

16 November 2022

M. Brunat-Mentigny

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A88751

16 November 2022

J. L. Chassard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A88751

16 November 2022

M. Mayer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A88751

16 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=88751

16 November 2022

publication date

1 January 1978

1 reference

full work available at URL

13 September 2017

http://link.springer.com/content/pdf/10.1007/978-3-642-81332-0_28.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Recent Results in Cancer Research

16 November 2022

published in

1 reference

13 September 2017

68

1 reference

13 September 2017

186-191

1 reference

Prognostic value of alpha-fetoprotein radioimmunoassay in surgically treated patients with embryonal cell carcinoma of the testis

13 September 2017

2

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

The importance of gonadothropin assays in the clinical follow up patients with germinal tumors of the testis

16 November 2022

3

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Re-Exploration for Retroperitoneal Lymph Node Metastases from Testis Tumors

16 November 2022

4

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Serum alpha1-foetoprotein levels in 153 male patients with germ cell tumours

16 November 2022

6

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Human chorionic gonadotropin (HCG) in monitoring the course of testicular tumours

16 November 2022

7

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

The Role of Radiation Therapy in the Treatment of Germinal Cell Tumors of the Testis Other than Pure Seminoma

16 November 2022

8

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Prognosis for pathologic stage I non-seminomatous germ cell tumors of the testis managed by retroperitoneal lymphadenectomy

16 November 2022

10

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Serum-alpha1-fetoprotein in patients with testicular tumours

16 November 2022

11

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Radiation therapy in malignant testis tumors.Part II: Carcinoma

16 November 2022

13

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer

16 November 2022

14

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Serum alpha1-fetoprotein and H.C.G. in patients with testicular tumours

16 November 2022

15

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

The value of chemotherapy in the treatment of testicular dysembryoplastic tumors

16 November 2022

16

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Cure of metastatic tumours by chemotherapy

16 November 2022

17

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Malignant tumors of the testis: Analysis of treatment results and sites and causes of failure

16 November 2022

18

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Combination chemotherapy in germinal cell tumors

16 November 2022

19

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Surgical Management of Testis Tumor

16 November 2022

20

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Alpha-1 antitrypsin (AAT) and alphafoetoprotein (AFP) in sera of patients with germ-cell neoplasms: Value as tumour markers in patients with endodermal sinus tumour (yolk sac tumour)

16 November 2022

21

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Alpha-fetoprotein and germ cell tumors: a possible role of yolk sac tumor in production of alpha-fetoprotein.

16 November 2022

22

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Multiple Antigens as Marker Substances in Germinal Tumors of the Testis

16 November 2022

23

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

Current dilemmas in the management of non-seminomatous germ cell tumors of the testis

16 November 2022

24

1 reference

https://api.crossref.org/works/10.1007/978-3-642-81332-0_28

16 November 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=88751

16 November 2022

1 reference